BioPassport Token

Halal Rating :
Comfortable
Contract: 0xc07A150ECAdF2cc352f5586396e344A6b17625EB
Last Price $0.001 Last updated:
Rank 1112
1D Change -2.37 %
Market Cap $7.43m
Circulating supply 7,399,483,542
Maximum supply 8,800,000,000

Crypto Overview

Categories
  • Ethereum Ecosystem
  • DWF Labs Portfolio

Purpose and Utility

BioPassport Token (BIOT) is designed to power a healthcare data management platform that aims to provide secure storage and sharing of medical information, including COVID-19 test results and vaccination records. The token serves as the native currency within the BioPassport ecosystem for paying for services and incentivizing data sharing.

Business Model Assessment

The business model appears to focus on legitimate healthcare data management, which aligns with halal principles as it provides actual utility in healthcare information management. The platform aims to connect healthcare providers, patients, and research institutions in a secure and transparent manner.

Real-World Adoption

Current adoption and usage metrics for BIOT are limited. While the project has announced several partnerships in the healthcare sector, verifiable evidence of widespread implementation is scarce.

Development Activity

The project's development activity appears to be minimal based on public repositories and update frequency. The team maintains some presence on social media but technical updates are infrequent.

Token Distribution

The token distribution information is not readily available in detail, which creates some opacity regarding the concentration of tokens among founders and early investors. However, this lack of transparency does not automatically make the project haram.

Technology and Revenue Model

The platform's core technology focuses on data management and access control, which does not involve any inherently haram activities like interest-bearing mechanisms or gambling. The revenue model is based on legitimate service fees for platform usage.

Rating Justification

Member Vote

Agree: 0 Disagree: 0

Login to vote on this

Comments